PortfoliosLab logoPortfoliosLab logo
CAT vs. AXSM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CAT vs. AXSM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Caterpillar Inc. (CAT) and Axsome Therapeutics, Inc. (AXSM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CAT achieves a 43.10% return, which is significantly higher than AXSM's 19.36% return. Over the past 10 years, CAT has underperformed AXSM with an annualized return of 28.72%, while AXSM has yielded a comparatively higher 39.83% annualized return.


CAT

1D
0.70%
1M
-17.66%
6M
24.42%
YTD
43.10%
1Y
87.70%
3Y*
43.33%
5Y*
33.84%
10Y*
28.72%
ALL TIME*
10.47%

AXSM

1D
-7.10%
1M
-9.42%
6M
18.31%
YTD
19.36%
1Y
115.02%
3Y*
41.26%
5Y*
35.01%
10Y*
39.83%
ALL TIME*
34.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$153.10M$171.36M$209.26M
$2.66B$2.67B$2.93B

CAT vs. AXSM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CAT
Caterpillar Inc.
43.10%60.30%24.66%25.95%18.60%15.95%26.97%19.51%-17.56%75.03%
AXSM
Axsome Therapeutics, Inc.
19.36%115.86%6.31%3.19%104.16%-53.63%-21.18%3,565.25%-49.64%-17.04%

Correlation

The correlation between CAT and AXSM is 0.20, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.20

Correlation (3Y)
Balances recent behavior with more history.

0.21

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.19

Correlation (10Y)
Provides a long-term view across more market conditions.

0.16

Correlation (All Time)
Calculated using the full available price history since Nov 19, 2015

0.16

Fundamentals

Market Cap

CAT:

$375.33B

AXSM:

$11.22B

EPS

CAT:

$20.10

AXSM:

-$3.72

PS Ratio

CAT:

5.40

AXSM:

15.58

PB Ratio

CAT:

20.34

AXSM:

204.46

Total Revenue (TTM)

CAT:

$70.76B

AXSM:

$708.24M

Gross Profit (TTM)

CAT:

$23.01B

AXSM:

$655.82M

EBITDA (TTM)

CAT:

$15.31B

AXSM:

-$172.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CAT vs. AXSM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CAT
CAT Risk / Return Rank: 9292
Overall Rank
CAT Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
CAT Sortino Ratio Rank: 9292
Sortino Ratio Rank
CAT Omega Ratio Rank: 9090
Omega Ratio Rank
CAT Calmar Ratio Rank: 8989
Calmar Ratio Rank
CAT Martin Ratio Rank: 9595
Martin Ratio Rank

AXSM
AXSM Risk / Return Rank: 9696
Overall Rank
AXSM Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AXSM Sortino Ratio Rank: 9797
Sortino Ratio Rank
AXSM Omega Ratio Rank: 9595
Omega Ratio Rank
AXSM Calmar Ratio Rank: 9797
Calmar Ratio Rank
AXSM Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CAT vs. AXSM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Caterpillar Inc. (CAT) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CATAXSMDifference
Sharpe ratioReturn per unit of total volatility

-0.44

Sortino ratioReturn per unit of downside risk

-1.03

Omega ratioGain probability vs. loss probability

1.37

1.47

-0.11

Calmar ratioReturn relative to maximum drawdown

3.34

6.25

-2.91

Martin ratioReturn relative to average drawdown

13.81

18.02

-4.21

CAT vs. AXSM - Sharpe Ratio Comparison

The current CAT Sharpe Ratio is 2.25, which is comparable to the AXSM Sharpe Ratio of 2.69. The chart below compares the historical Sharpe Ratios of CAT and AXSM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CAT vs. AXSM - Drawdown Comparison

The maximum CAT drawdown since its inception was -73.43%, smaller than the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for CAT and AXSM.


Loading charts...

Drawdown Indicators


CATAXSMDifference

Max Drawdown

Largest peak-to-trough decline

-73.43%

-86.65%

+13.22%

Max Drawdown (1Y)

Largest decline over 1 year

-26.36%

-18.50%

-7.86%

Max Drawdown (3Y)

Largest decline over 3 years

-34.05%

-32.69%

-1.36%

Max Drawdown (5Y)

Largest decline over 5 years

-34.05%

-61.08%

+27.03%

Max Drawdown (10Y)

Largest decline over 10 years

-43.36%

-81.26%

+37.90%

Current Drawdown

Current decline from peak

-23.34%

-14.57%

-8.77%

Average Drawdown

Average peak-to-trough decline

-19.71%

-39.06%

+19.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.41%

6.41%

0.00%

Volatility

CAT vs. AXSM - Volatility Comparison

The current volatility for Caterpillar Inc. (CAT) is 11.37%, while Axsome Therapeutics, Inc. (AXSM) has a volatility of 14.94%. This indicates that CAT experiences smaller price fluctuations and is considered to be less risky than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CATAXSMDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.37%

14.94%

-3.57%

Volatility (6M)

Calculated over the trailing 6-month period

31.53%

28.72%

+2.81%

Volatility (1Y)

Calculated over the trailing 1-year period

39.11%

42.96%

-3.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.62%

70.11%

-38.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.31%

90.38%

-59.07%

Dividends

CAT vs. AXSM - Dividend Comparison

CAT's dividend yield for the trailing twelve months is around 0.76%, while AXSM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AXSM
Axsome Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CAT
Caterpillar Inc.
0.76%1.02%1.49%1.69%1.93%2.07%2.26%2.56%2.58%1.97%3.32%4.33%

Financials

CAT vs. AXSM - Financials Comparison

This section allows you to compare key financial metrics between Caterpillar Inc. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

CAT vs. AXSM - Profitability Comparison

The chart below illustrates the profitability comparison between Caterpillar Inc. and Axsome Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

CAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Caterpillar Inc. reported a gross profit of 6.11B and revenue of 17.42B. Therefore, the gross margin over that period was 35.1%.

AXSM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.

CAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Caterpillar Inc. reported an operating income of 3.09B and revenue of 17.42B, resulting in an operating margin of 17.7%.

AXSM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.

CAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Caterpillar Inc. reported a net income of 2.55B and revenue of 17.42B, resulting in a net margin of 14.6%.

AXSM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.


Frequently Asked Questions


CAT and AXSM have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AXSM has higher volatility (14.94%) compared to CAT (11.37%). In terms of maximum drawdown, CAT dropped -73.43% vs AXSM's -86.65%.

AXSM currently has the higher Sharpe Ratio (2.69 vs 2.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CAT and AXSM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer